- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 46.86M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $8.71M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $8.36M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.06M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.67M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $17.23M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $16.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.86M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.88M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.83M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 77.32M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $59K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.88M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$8.03M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$8.67M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.77M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.67M |
| Net Income | Q1 2025 · Mar 31, 2024 | $417K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$282K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $4.68M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.72M |